Nothing Special   »   [go: up one dir, main page]

PH22480A - New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds - Google Patents

New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds

Info

Publication number
PH22480A
PH22480A PH33507A PH33507A PH22480A PH 22480 A PH22480 A PH 22480A PH 33507 A PH33507 A PH 33507A PH 33507 A PH33507 A PH 33507A PH 22480 A PH22480 A PH 22480A
Authority
PH
Philippines
Prior art keywords
compounds
sulphonylaminoethyl
new
pharmaceutical compositions
compositions containing
Prior art date
Application number
PH33507A
Inventor
Nickl Dr Josef
Haarmann Dr Walter
Ballhause Helmut
Weisenberger Dr Johannes
Heckel Dr Armin
Mueller Dr Erich
Narr Dr Berthold
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853508692 external-priority patent/DE3508692A1/en
Priority claimed from DE19853541854 external-priority patent/DE3541854A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PH22480A publication Critical patent/PH22480A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH33507A 1985-03-12 1986-03-11 New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds PH22480A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853508692 DE3508692A1 (en) 1985-03-12 1985-03-12 3-[4-(2-Benzenesulfonylaminoethyl)benzoyl]propionic acid, medicaments containing this compound and processes for their preparation
DE19853541854 DE3541854A1 (en) 1985-11-27 1985-11-27 Novel sulphonylaminoethyl compounds, medicaments containing these compounds and processes for their preparation

Publications (1)

Publication Number Publication Date
PH22480A true PH22480A (en) 1988-09-12

Family

ID=25830225

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33507A PH22480A (en) 1985-03-12 1986-03-11 New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds

Country Status (11)

Country Link
EP (1) EP0194548A3 (en)
AU (1) AU5461286A (en)
DK (1) DK110886A (en)
ES (5) ES8800664A1 (en)
FI (1) FI860971A (en)
GR (1) GR860654B (en)
HU (1) HU195770B (en)
IL (1) IL78079A0 (en)
NO (1) NO860918L (en)
PH (1) PH22480A (en)
PT (1) PT82169B (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535167A1 (en) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh NEW SULFONYL-PHENYL (ALKYL) AMINES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS
DE3623944A1 (en) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K NEW BENZOLSULFONAMIDO INDANYL COMPOUNDS, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
TR24291A (en) * 1986-10-27 1991-07-30 Stockhausen Chem Fab Gmbh WITH N, N-DISUEBSTITUEE BETA -AMINOPROP- IONIC ACID COMPOUNDS OF LEATHER AND QUARTERS AND
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
US4752613A (en) * 1987-08-03 1988-06-21 E. R. Squibb & Sons, Inc. Sulphonamidothienylcarboxylic acid compounds
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
AT393962B (en) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistic pharmaceutical combination with a content of a phosphodiesterase inhibitor and the use thereof
DE3819052A1 (en) * 1988-06-04 1989-12-07 Basf Ag NEW SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US5106991A (en) * 1989-06-02 1992-04-21 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US4975452A (en) * 1989-06-02 1990-12-04 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
DE4035961A1 (en) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
DE4213919A1 (en) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co Pyridazinone derivatives and processes for their preparation
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (en) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co Substituted biphenylsulfonamide endothelin antagonist
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
SG87053A1 (en) 1996-02-20 2002-03-19 Bristol Myers Squibb Co High melt polymorth of the compound n-(3,4-dimethyl-5-isoxazolyl)-4'- (2-oxazolyl) [1,1'-biphenyl]-2-sulfonamide
US5958905A (en) * 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
TR200202738T2 (en) 1997-04-28 2003-03-21 Texas Biotechnology Corporation Sulfanoamides used in the treatment of endothelin related diseases
IL144708A0 (en) 1999-03-19 2002-06-30 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamide derivatives
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
PT2069312E (en) 2006-07-25 2013-01-24 Cephalon Inc Pyridizinone derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (en) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim NEW SULPHONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3535167A1 (en) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh NEW SULFONYL-PHENYL (ALKYL) AMINES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
ES552870A0 (en) 1987-11-16
EP0194548A2 (en) 1986-09-17
DK110886A (en) 1986-09-13
ES8800664A1 (en) 1987-11-16
ES557211A0 (en) 1987-05-16
ES557210A0 (en) 1987-05-01
ES557213A0 (en) 1987-05-16
EP0194548A3 (en) 1988-08-17
ES557212A0 (en) 1987-05-16
HU195770B (en) 1988-07-28
FI860971A0 (en) 1986-03-10
AU5461286A (en) 1986-10-16
ES8705856A1 (en) 1987-05-16
FI860971A (en) 1986-09-13
NO860918L (en) 1986-09-15
ES8705857A1 (en) 1987-05-16
PT82169A (en) 1986-04-01
PT82169B (en) 1988-01-04
HUT42062A (en) 1987-06-29
ES8705855A1 (en) 1987-05-16
DK110886D0 (en) 1986-03-11
GR860654B (en) 1986-07-11
IL78079A0 (en) 1986-07-31
ES8705378A1 (en) 1987-05-01

Similar Documents

Publication Publication Date Title
PH22480A (en) New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds
ZA864602B (en) 2-arylimidazoles and pharmaceutical compositions containing these compounds
ZA867318B (en) Pharmaceutical composition
GB8602787D0 (en) Pharmaceutical composition
GB8602788D0 (en) Pharmaceutical composition
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8530796D0 (en) Pharmaceutical composition
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
GB2171600B (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
GB8613320D0 (en) Pharmaceutical composition
GB8515170D0 (en) Pharmaceutical compositions
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
SG92592G (en) Pharmaceutical compositions containing azanaphthalenes
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL78918A0 (en) Substituted hexahydro-arylquinolizines and pharmaceutical compositions containing them
IL79497A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them
GB2182561B (en) Pharmaceutical compositions
IL78707A0 (en) Rioprostil-polyvinylpyrrolidone complex and pharmaceutical compositions containing it
EP0193194A3 (en) 15(r)-5-fluoroprostacyclins and pharmaceutical compositions containing said compounds
GB8502887D0 (en) Pharmaceutical compositions
HK93592A (en) Pharmaceutical compositions containing azanaphthalenes
NZ217898A (en) Pharmaceutical compositions containing aroylthiazolones